Skipping toward personalized molecular medicine - PubMed (original) (raw)
Editorial
. 2007 Dec 27;357(26):2719-22.
doi: 10.1056/NEJMe0707795.
- PMID: 18160693
- DOI: 10.1056/NEJMe0707795
Editorial
Skipping toward personalized molecular medicine
Eric P Hoffman. N Engl J Med. 2007.
No abstract available
Comment on
- Local dystrophin restoration with antisense oligonucleotide PRO051.
van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer-Bout M, den Dunnen JT, Koop K, van der Kooi AJ, Goemans NM, de Kimpe SJ, Ekhart PF, Venneker EH, Platenburg GJ, Verschuuren JJ, van Ommen GJ. van Deutekom JC, et al. N Engl J Med. 2007 Dec 27;357(26):2677-86. doi: 10.1056/NEJMoa073108. N Engl J Med. 2007. PMID: 18160687 Clinical Trial.
Similar articles
- Local dystrophin restoration with antisense oligonucleotide PRO051.
van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer-Bout M, den Dunnen JT, Koop K, van der Kooi AJ, Goemans NM, de Kimpe SJ, Ekhart PF, Venneker EH, Platenburg GJ, Verschuuren JJ, van Ommen GJ. van Deutekom JC, et al. N Engl J Med. 2007 Dec 27;357(26):2677-86. doi: 10.1056/NEJMoa073108. N Engl J Med. 2007. PMID: 18160687 Clinical Trial. - Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challenge.
Wood MJ. Wood MJ. Sci Transl Med. 2010 Mar 31;2(25):25ps15. doi: 10.1126/scitranslmed.3000512. Sci Transl Med. 2010. PMID: 20424011 - Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.
Aartsma-Rus A, Janson AA, van Ommen GJ, van Deutekom JC. Aartsma-Rus A, et al. BMC Med Genet. 2007 Jul 5;8:43. doi: 10.1186/1471-2350-8-43. BMC Med Genet. 2007. PMID: 17612397 Free PMC article. - Splicing intervention for Duchenne muscular dystrophy.
McClorey G, Fletcher S, Wilton S. McClorey G, et al. Curr Opin Pharmacol. 2005 Oct;5(5):529-34. doi: 10.1016/j.coph.2005.06.001. Curr Opin Pharmacol. 2005. PMID: 16085461 Review. - Exon-skipping therapy for Duchenne muscular dystrophy.
Nakamura A, Takeda S. Nakamura A, et al. Neuropathology. 2009 Aug;29(4):494-501. doi: 10.1111/j.1440-1789.2009.01028.x. Epub 2009 May 22. Neuropathology. 2009. PMID: 19486303 Review.
Cited by
- Saponins enhance exon skipping of 2'-O-methyl phosphorothioate oligonucleotide in vitro and in vivo.
Wang M, Wu B, Shah SN, Lu P, Lu Q. Wang M, et al. Drug Des Devel Ther. 2018 Oct 31;12:3705-3715. doi: 10.2147/DDDT.S179008. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30464402 Free PMC article. - Experimental therapeutics in hereditary neuropathies: the past, the present, and the future.
Herrmann DN. Herrmann DN. Neurotherapeutics. 2008 Oct;5(4):507-15. doi: 10.1016/j.nurt.2008.07.001. Neurotherapeutics. 2008. PMID: 19019301 Free PMC article. Review. - What ever happened to N-of-1 trials? Insiders' perspectives and a look to the future.
Kravitz RL, Duan N, Niedzinski EJ, Hay MC, Subramanian SK, Weisner TS. Kravitz RL, et al. Milbank Q. 2008 Dec;86(4):533-55. doi: 10.1111/j.1468-0009.2008.00533.x. Milbank Q. 2008. PMID: 19120979 Free PMC article. - Therapeutic potential of splice-switching oligonucleotides.
Bauman J, Jearawiriyapaisarn N, Kole R. Bauman J, et al. Oligonucleotides. 2009 Mar;19(1):1-13. doi: 10.1089/oli.2008.0161. Oligonucleotides. 2009. PMID: 19125639 Free PMC article. Review. - Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm.
Doran P, Wilton SD, Fletcher S, Ohlendieck K. Doran P, et al. Proteomics. 2009 Feb;9(3):671-85. doi: 10.1002/pmic.200800441. Proteomics. 2009. PMID: 19132684 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources